Deals In Depth: April 2014
Executive Summary
Celgene penned two major collaborations; Zimmer and Biomet created an orthopedics device giant in their $13.4B merger. Biopharma financing totaled $2.7B in April; and device funding reached $354M, with two IPOs representing 38% of the total.